TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 2573572

Group type: EXPERIMENTAL
Intervention: Somatostatin (250-micrograms bolus and 250-micrograms per hr infusion, with repeat bolus and doubling of the infusion if bleeding was not controlled)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Somatostatin
Number of subjects: 102
Study: 1026339

Group type: EXPERIMENTAL
Intervention: Cytosine arabinoside
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Methotrexate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hydroxyurea
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cycle-sensitive schedule with cytosine arabinoside
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intensive-chemotherapy schedule
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Initial LI greater than 60% reduction in circulating leukemia cells
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Initial kinetic measurements
Number of subjects: 0
Study: 31672481

Group type: EXPERIMENTAL
Intervention: Practical blood flow restriction (pBFR) during boat‐ and indoor‐rowing training (n=16; 4 female, 12 male)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control group (CON) without pBFR (n=15; 4 female, 11 male)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Practical blood flow restriction (pBFR)
Number of subjects: 31
Study: 31370981

Group type: EXPERIMENTAL
Intervention: Varenicline (VAR)
Number of subjects: 137

Group type: COMPARATOR
Intervention: Nicotine Replacement Therapy (NRT)
Number of subjects: 137
Study: 27932522

Group type: EXPERIMENTAL
Intervention: Triphala and Ela decoction (Group A)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Chlorhexidine mouthwash (Group B)
Number of subjects: 60
Study: 25099940

Group type: EXPERIMENTAL
Intervention: Normal colposcopy examination
Number of subjects: 727
Study: 24231653

Group type: EXPERIMENTAL
Intervention: Distraction group (performed a distracting tone‐detection task)
Number of subjects: 164

Group type: COMPARATOR
Intervention: Control group (did not perform a distracting task)
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Distraction task engagement
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Distraction effectiveness
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Executive functioning and pain affect
Number of subjects: 164
Study: 23064279

Group type: EXPERIMENTAL
Intervention: Encouragement condition (1-page letter and phone call reminder)
Number of subjects: 1347

Group type: COMPARATOR
Intervention: Control condition (no encouragement)
Number of subjects: 1347

Group type: EXPERIMENTAL
Intervention: Encouragement condition
Number of subjects: 1347

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 1347
Study: 20521030

Group type: COMPARATOR
Intervention: Baclofen (60, 90 mg/day) for 16 days
Number of subjects: 21

Group type: COMPARATOR
Intervention: Mirtazapine (30 mg/day) for 14 days
Number of subjects: 21
Study: 18460109

Group type: EXPERIMENTAL
Intervention: Ondansetron
Number of subjects: 110

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 110
Study: 16002558

Group type: EXPERIMENTAL
Intervention: Histamine (0.32 microg.kg(‐1).min(‐1) over 30 min)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Cimetidine (2.3 mg/min over 50 min)
Number of subjects: 18
Study: 12560436

Group type: EXPERIMENTAL
Intervention: Progressive upper-body exercise program (8-week duration, resistance training plus aerobic exercise using a Monark Rehab Trainer arm ergometer)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Progressive upper-body exercise program
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 14
Study: 10891899

Group type: EXPERIMENTAL
Intervention: Carotid endarterectomy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Best medical therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low postrandomization MMSE score
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Stroke after randomization
Number of subjects: 0
Study: 9294799

Group type: EXPERIMENTAL
Intervention: Modified tension band (AO technique)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Two parallel 4.5‐millimeter interfragmentary lag screws
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Four‐millimeter cannulated lag screws with a tension band wired through the screws
Number of subjects: 18
Study: 8320510

Group type: EXPERIMENTAL
Intervention: Grommet insertion with adenoidectomy
Number of subjects: 78

Group type: COMPARATOR
Intervention: Grommet insertion without adenoidectomy
Number of subjects: 78

Group type: COMPARATOR
Intervention: Adenoidectomy alone
Number of subjects: 78
Study: 2951520

Group type: EXPERIMENTAL
Intervention: Laparoscopic uterine nerve ablation
Number of subjects: 21
Study: 29806296

Group type: EXPERIMENTAL
Intervention: Interrupted suture at exercise position (observation group)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Interrupted suture at flexion knee position (control group)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 84
Study: 27450907

Group type: EXPERIMENTAL
Intervention: Internet-based brief intervention with normative drinking feedback
Number of subjects: 734
Study: 24937302

Group type: EXPERIMENTAL
Intervention: Clinical Teaching Associate (CTA) model
Number of subjects: 60

Group type: COMPARATOR
Intervention: Traditional training
Number of subjects: 60
Study: 22543874

Group type: EXPERIMENTAL
Intervention: Promotion of dietary guidelines by nurse practitioners
Number of subjects: 0
Study: 20550224

Group type: EXPERIMENTAL
Intervention: Leukotriene receptor antagonists (LTRAs)
Number of subjects: 326

Group type: COMPARATOR
Intervention: Inhaled corticosteroids (ICS)
Number of subjects: 326
Study: 18457822

Group type: EXPERIMENTAL
Intervention: Experimental 'Think Biology' program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional cold/flu education program
Number of subjects: 0
Study: 15673691

Group type: EXPERIMENTAL
Intervention: MCI-196 6 g/day
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study: 12627359

Group type: EXPERIMENTAL
Intervention: Oral valacyclovir, 2 g q.i.d.
Number of subjects: 168

Group type: COMPARATOR
Intervention: Intravenous ganciclovir, 5 mg/kg q12h for 1 week, then 6 mg/kg once daily for 5 days per week
Number of subjects: 168
Study: 10573697

Group type: EXPERIMENTAL
Intervention: Gastric fluid smear
Number of subjects: 1003

Group type: EXPERIMENTAL
Intervention: Diagnostic criteria for infection
Number of subjects: 1003

Group type: EXPERIMENTAL
Intervention: Causative organisms
Number of subjects: 1003
Study: 8917146

Group type: EXPERIMENTAL
Intervention: Two cards listing seven core health maintenance concerns
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Brief session with a nurse to identify health risks and develop a plan
Number of subjects: 0
Study: 7985452

Group type: EXPERIMENTAL
Intervention: Basal Body Temperature (BBT) graph monitoring
Number of subjects: 73
Study: 3534249

Group type: EXPERIMENTAL
Intervention: ECG servo-assistance
Number of subjects: 60

Group type: COMPARATOR
Intervention: Three images per second technique
Number of subjects: 60
Study: 30102085

Group type: EXPERIMENTAL
Intervention: Bone-borne expander
Number of subjects: 40

Group type: COMPARATOR
Intervention: Tooth-borne expander
Number of subjects: 40
Study: 27492941

Group type: EXPERIMENTAL
Intervention: Cardiac rehabilitation (12 weeks of physical exercise and monthly psycho-educational consultations)
Number of subjects: 147

Group type: COMPARATOR
Intervention: Usual care (without structured physical exercise or psycho-educational consultations)
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: Cardiac rehabilitation
Number of subjects: 147
Study: 23635809

Group type: EXPERIMENTAL
Intervention: Nurse practitioner/community health worker (NP/CHW) care
Number of subjects: 525

Group type: COMPARATOR
Intervention: Enhanced usual care
Number of subjects: 525
Study: 23094777

Group type: EXPERIMENTAL
Intervention: TVT-O
Number of subjects: 197

Group type: COMPARATOR
Intervention: TVT-S H
Number of subjects: 197

Group type: COMPARATOR
Intervention: TVT-S U
Number of subjects: 197
Study: 20223578

Group type: EXPERIMENTAL
Intervention: Kneeling position
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Standing on a taboret
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Standing on the floor
Number of subjects: 24
Study: 18678160

Group type: EXPERIMENTAL
Intervention: Blood-letting puncture plus red-hot needle therapy
Number of subjects: 129

Group type: COMPARATOR
Intervention: Routine acupuncture
Number of subjects: 129
Study: 16450688

Group type: EXPERIMENTAL
Intervention: Tramadol 37.5 mg/APAP 325 mg (mean, 4.3 tablets)
Number of subjects: 305

Group type: COMPARATOR
Intervention: Codeine 30 mg/APAP 300 mg (mean, 4.6 tablets)
Number of subjects: 305

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 305
Study: 12891252

Group type: EXPERIMENTAL
Intervention: G‐CSF (filgrastim) 5 mg/kg/day
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (0.9% NaCl)
Number of subjects: 40
Study: 10367605

Group type: EXPERIMENTAL
Intervention: Low total cholesterol concentrations (<4.14 mmol/liter)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Total cholesterol
Number of subjects: 121

Group type: COMPARATOR
Intervention: Triglycerides
Number of subjects: 121

Group type: COMPARATOR
Intervention: Low-density lipoprotein cholesterol
Number of subjects: 121

Group type: COMPARATOR
Intervention: Ratio of total cholesterol to high-density lipoprotein cholesterol
Number of subjects: 121
Study: 8763372

Group type: EXPERIMENTAL
Intervention: Cocaine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Co‐phenylcaine forte
Number of subjects: 0
Study: 1678735

Group type: EXPERIMENTAL
Intervention: Metadoxine 900 mg twice daily eluted in 500 ml of saline infusion
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group: 500 ml of saline infusion twice daily with equivalent doses of pyridoxine (40 mg/die) every morning
Number of subjects: 40
Study: 7138952

Group type: EXPERIMENTAL
Intervention: EEG biofeedback training (suppression of 3‐ to 7‐Hz activity)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: EEG biofeedback training (enhancement of 12‐ to 15‐Hz activity)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: EEG biofeedback training (simultaneous suppression of 3‐ to 7‐Hz and enhancement of 11‐ to 19‐Hz activity)
Number of subjects: 8
Study: 30758402

Group type: EXPERIMENTAL
Intervention: Iodoform paste (iodoform + camphorated parachlorophenol + ointment comprising prednisolone acetate 5.0 mg and rifamycin 1.5 mg)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Calen®/ZO paste
Number of subjects: 23
Study: 29046518

Group type: EXPERIMENTAL
Intervention: Oxycodone (0.05 mg/kg)
Number of subjects: 120
Study: 27089522

Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 793

Group type: EXPERIMENTAL
Intervention: Nortriptyline
Number of subjects: 793
Study: 24333062

Group type: EXPERIMENTAL
Intervention: Erythrocytapheresis
Number of subjects: 62

Group type: COMPARATOR
Intervention: Whole blood phlebotomy
Number of subjects: 62
Study: 22311382

Group type: EXPERIMENTAL
Intervention: Memantine (40 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 19083205

Group type: EXPERIMENTAL
Intervention: Computer-assisted surgery
Number of subjects: 87

Group type: COMPARATOR
Intervention: Conventional technique
Number of subjects: 87
Study: 17314582

Group type: EXPERIMENTAL
Intervention: Intra-articular injection of ultracain
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo injection (saline)
Number of subjects: 19
Study: 15366332

Group type: EXPERIMENTAL
Intervention: Lantigen B
Number of subjects: 212

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 212
Study: 11196267

Group type: EXPERIMENTAL
Intervention: Granulocyte colony-stimulating factor (G-CSF) 5.0 microg/kg per day
Number of subjects: 123

Group type: COMPARATOR
Intervention: Granulocyte colony-stimulating factor (G-CSF) 10.0 microg/kg per day
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: ICE chemotherapy (ifosfamide, carboplatin, etoposide)
Number of subjects: 123
Study: 9638315

Group type: EXPERIMENTAL
Intervention: 40 mg pantoprazole daily
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 300 mg ranitidine daily
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 8052927

Group type: EXPERIMENTAL
Intervention: Pulse methylprednisolone (400 mg/day)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Oral prednisolone (50 mg/day)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Pulse methylprednisolone
Number of subjects: 102

Group type: COMPARATOR
Intervention: Oral prednisolone
Number of subjects: 102
Study: 2720577

Group type: EXPERIMENTAL
Intervention: 100 mg MS Contin tablet
Number of subjects: 51

Group type: COMPARATOR
Intervention: Three 30 mg MS Contin tablets
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Controlled-release morphine
Number of subjects: 51
Study: 4417355

Group type: EXPERIMENTAL
Intervention: Mammography and clinical examination (screening)
Number of subjects: 1000
Study: 31154571

Group type: EXPERIMENTAL
Intervention: 30-mg zinc gluconate for 12 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo for 12 weeks
Number of subjects: 60
Study: 31011823

Group type: EXPERIMENTAL
Intervention: Azithromycin 1.5% eyedrops
Number of subjects: 169

Group type: COMPARATOR
Intervention: Oral doxycycline
Number of subjects: 169
Study: 28834897

Group type: EXPERIMENTAL
Intervention: 50% xenon
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: 75% xenon
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: 100% xenon
Number of subjects: 160

Group type: COMPARATOR
Intervention: Control (50% nitrogen)
Number of subjects: 160
Study: 25968598

Group type: EXPERIMENTAL
Intervention: Sulforaphane (60 mg daily for 6 months)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Sulforaphane
Number of subjects: 78
Study: 22411260

Group type: EXPERIMENTAL
Intervention: Biodentine
Number of subjects: 397

Group type: COMPARATOR
Intervention: Z100®
Number of subjects: 397

Group type: EXPERIMENTAL
Intervention: Biodentine covered with Z100®
Number of subjects: 397
Study: 22090487

Group type: EXPERIMENTAL
Intervention: d-amphetamine 10 mg
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: d-amphetamine 20 mg
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 19085178

Group type: EXPERIMENTAL
Intervention: Trans-dermal fentanyl (TDF) patch (Group F, n=25)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Sustained-release oral morphine (SRM) (Group M, n=25)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Trans-dermal fentanyl (TDF) patch (Group F)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Sustained-release oral morphine (SRM) (Group M)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both groups (TDF and SRM)
Number of subjects: 50
Study: 16529596

Group type: EXPERIMENTAL
Intervention: More frequent vital sign evaluation
Number of subjects: 0
Study: 12893551

Group type: EXPERIMENTAL
Intervention: Peer tutoring groups
Number of subjects: 0

Group type: COMPARATOR
Intervention: Medical teacher groups
Number of subjects: 0
Study: 11069570

Group type: EXPERIMENTAL
Intervention: Probiotic-supplemented formulas (Bifidobacterium lactis Bb-12 or Lactobacillus strain GG)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Probiotic-supplemented formulas
Number of subjects: 27

Group type: COMPARATOR
Intervention: Unsupplemented formula
Number of subjects: 27
Study: 9176021

Group type: EXPERIMENTAL
Intervention: Hydroxyurea
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 1485612

Group type: EXPERIMENTAL
Intervention: Intervention
Number of subjects: 928
Study: 3510539

Group type: EXPERIMENTAL
Intervention: Phenytoin
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 21
Study: 31673048

Group type: EXPERIMENTAL
Intervention: miRNA profile assessment using small RNA sequencing
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Assessment of miRNAs from the C14MC cluster
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Analysis of confounders (age, BMI, time to centrifugation)
Number of subjects: 66
Study: 29659193

Group type: EXPERIMENTAL
Intervention: Orlistat 27-mg chewable tablet
Number of subjects: 192

Group type: COMPARATOR
Intervention: Orlistat 60-mg capsule
Number of subjects: 192

Group type: COMPARATOR
Intervention: Orlistat 120-mg capsules (2 60-mg capsules)
Number of subjects: 192
Study: 27054284

Group type: EXPERIMENTAL
Intervention: Earplugs
Number of subjects: 51

Group type: COMPARATOR
Intervention: Unprotected group
Number of subjects: 51
Study: 24073873

Group type: EXPERIMENTAL
Intervention: FOS (4 g × 2 times/d)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (sucrose group)
Number of subjects: 0
Study: 22013924

Group type: EXPERIMENTAL
Intervention: UVB exposure once a week
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: UVB exposure every second week
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: UVB exposure once every fourth week
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 60
Study: 19965647

Group type: EXPERIMENTAL
Intervention: All-trans retinoic acid (ATRA) added to daunorubicin/Ara-C/thioguanine chemotherapy
Number of subjects: 1075

Group type: COMPARATOR
Intervention: Daunorubicin/Ara-C/thioguanine chemotherapy without ATRA
Number of subjects: 1075

Group type: EXPERIMENTAL
Intervention: ATRA in patients with lower MN1 levels
Number of subjects: 1075

Group type: EXPERIMENTAL
Intervention: ATRA in patients with normal karyotype
Number of subjects: 1075
Study: 17493066

Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy (SLIT) with latex extract
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 16275834

Group type: EXPERIMENTAL
Intervention: Multivariate model including T2 burden of disease
Number of subjects: 1328

Group type: COMPARATOR
Intervention: Multivariate model without T2 burden of disease
Number of subjects: 1328
Study: 14608241

Group type: EXPERIMENTAL
Intervention: Cortisol administration
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Cocaine administration
Number of subjects: 12
Study: 10499752

Group type: EXPERIMENTAL
Intervention: Catheter-over-the-needle group (Spinocath, 22-gauge)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Microcatheter-through-the-needle group (Portex, 28-gauge)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 20
Study: 8880369

Group type: EXPERIMENTAL
Intervention: Temporal gap condition
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control non-gap condition
Number of subjects: 0
Study: 1534955

Group type: EXPERIMENTAL
Intervention: Abdominal wall massage (20 min sessions, 9 sessions over 3 weeks)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Abdominal wall massage
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control phase (no massage)
Number of subjects: 16
Study: 6403101

Group type: EXPERIMENTAL
Intervention: Tamoxifen 20 mg daily for one year (premenoausal)
Number of subjects: 1005

Group type: EXPERIMENTAL
Intervention: Tamoxifen 20 mg daily for one year (postmenopausal)
Number of subjects: 1005

Group type: COMPARATOR
Intervention: No systemic treatment (controls, postmenopausal)
Number of subjects: 1005
Study: 31592997

Group type: EXPERIMENTAL
Intervention: On the Move (OTM) task-oriented intervention
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Standard of care impairment-based exercise intervention (STD)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 107
Study: 30316493

Group type: EXPERIMENTAL
Intervention: Behavioral guided self-help program
Number of subjects: 149

Group type: COMPARATOR
Intervention: Nonbehavioral guided self-help program
Number of subjects: 149
Study: 26496418

Group type: EXPERIMENTAL
Intervention: Tear SIgA during URTI
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Tear SIgA the week before URS
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Tear SIgA secretion rate <5.5 μg·min(‐1)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Tear SIgA secretion rate decrease >30%
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Tear SIgA secretion rate >5.5 μg·min(‐1) or no decrease of >30%
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Tear SIgA after exercise
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Saliva flow rate after exercise and during dehydration
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Saliva SIgA concentration after exercise and during dehydration
Number of subjects: 40
Study: 23230962

Group type: EXPERIMENTAL
Intervention: Formula feeding
Number of subjects: 0

Group type: COMPARATOR
Intervention: Breastfeeding promotion
Number of subjects: 0
Study: 21848963

Group type: EXPERIMENTAL
Intervention: Erythrocytapheresis
Number of subjects: 38

Group type: COMPARATOR
Intervention: Phlebotomy
Number of subjects: 38
Study: 19823859

Group type: EXPERIMENTAL
Intervention: Fingerstall packs filled with gauze and smeared with vaseline (group 1)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Silicon septal splint packs (group 2)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Haemostatic septal sutures (group 3)
Number of subjects: 48

Group type: COMPARATOR
Intervention: All groups combined
Number of subjects: 48
Study: 18039020

Group type: EXPERIMENTAL
Intervention: 2% sertaconazole solution
Number of subjects: 313

Group type: COMPARATOR
Intervention: 2% sertaconazole cream
Number of subjects: 313
Study: 15738534

Group type: EXPERIMENTAL
Intervention: Short-course RT (8 Gy x 2 days)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Split-course RT (5 Gy x 3; 3 Gy x 5)
Number of subjects: 300
Study: 12496749

Group type: EXPERIMENTAL
Intervention: Gemfibrozil 600 mg twice daily for 3 days
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 9794174

Group type: EXPERIMENTAL
Intervention: Highest quartile of exposure to p,p'‐DDE
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Total polychlorinated biphenyls (PCBs)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Lowest quartile of exposure to organochlorine compounds
Number of subjects: 180
Study: 8775841

Group type: EXPERIMENTAL
Intervention: Pharmacologic treatments for drug dependence
Number of subjects: 0
Study: 2198314

Group type: EXPERIMENTAL
Intervention: Four-drug regimen of rifampin, isoniazid, dapsone, and clofazimine for the first 3 months and clofazimine plus dapsone for the next 57 months
Number of subjects: 0

Group type: COMPARATOR
Intervention: Two-drug regimen of dapsone plus clofazimine for 60 months
Number of subjects: 0